Genus (LON:GNS) Posts Quarterly Earnings Results

Genus (LON:GNS) released its quarterly earnings results on Thursday. The company reported GBX 110.30 earnings per share for the quarter, Digital Look Earnings reports. Genus had a return on equity of 9.70% and a net margin of 7.07%.

Here are the key takeaways from Genus’ conference call:

• FY 2026 results were strong: adjusted profit before tax and adjusted EPS each rose 35%, while free cash flow increased to £62 million and leverage fell to 0.4x.
• Genus announced a £60 million share buyback for FY 2027 and recommended a 10% increase in the full-year dividend to 35.2 pence per share, reflecting confidence in cash generation and future growth.
• PIC delivered broad-based growth, including 52% royalty-revenue growth in China and market-share gains, while the new China joint venture is expected to support further expansion in the world’s largest porcine market.
• PRP regulatory progress continued with approvals or favorable determinations in Argentina, Canada, Uruguay, and Peru; commercialization is now beginning in selected Latin American markets, although approvals in Mexico and China remain pending.
• Management expects FY 2027 underlying adjusted profit before tax to be only moderately higher, with growth weighted toward the second half due to weak agricultural markets, North American disease pressures, lower Brazilian growth, depressed dairy conditions, and higher PRP and product-development costs.

Genus Price Performance

LON:GNS traded down GBX 74 during midday trading on Thursday, hitting GBX 2,160. 543,824 shares of the stock were exchanged, compared to its average volume of 769,729. Genus has a one year low of GBX 1,943 and a one year high of GBX 3,220. The company has a market capitalization of £1.43 billion, a price-to-earnings ratio of 30.42, a P/E/G ratio of 2.87 and a beta of 0.90. The business has a 50-day moving average price of GBX 2,223.11 and a two-hundred day moving average price of GBX 2,382.24. The company has a current ratio of 2.25, a quick ratio of 1.08 and a debt-to-equity ratio of 51.73.

Key Stories Impacting Genus

Here are the key news stories impacting Genus this week:

• Positive Sentiment: Genus launched a £60 million share buyback, signaling management’s confidence in the company’s long-term growth prospects and potentially supporting earnings per share. Genus Launches £60 Mln Share Buyback Programme
• Positive Sentiment: FY26 pretax profit increased, while the company also reduced leverage following developments involving its China joint venture. The improved profitability and balance-sheet progress provide support for the investment case. Genus FY26 Pretax Profit Rises
• Positive Sentiment: Berenberg reaffirmed its Buy rating and assigned a GBX 3,350 price target, indicating substantial potential upside from recent trading levels. Berenberg rating update
• Neutral Sentiment: Genus reported quarterly earnings per share of GBX 110.30, with a 9.70% return on equity and a 7.07% net margin. These results show continued profitability, but investors are weighing them against softer top-line performance and forward guidance. Genus quarterly earnings
• Negative Sentiment: The shares came under pressure after Genus reported a revenue shortfall and forecast only moderate operating-profit growth for FY27, raising concerns about near-term growth momentum. Genus Shares Fall as FY27 Growth Forecast Moderates
• Negative Sentiment: The combination of missed revenue expectations and cautious FY27 guidance overshadowed the higher profits and buyback, prompting investors to reassess Genus’s premium valuation. Genus Buyback and FY Results

Wall Street Analyst Weigh In

Separately, Berenberg Bank reissued a “buy” rating and issued a GBX 3,350 price objective on shares of Genus in a report on Thursday. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Genus has a consensus rating of “Buy” and an average price target of GBX 3,216.67.

Insider Transactions at Genus

In other news, insider Celia Baxter purchased 2,336 shares of the firm’s stock in a transaction on Friday, June 26th. The stock was purchased at an average cost of GBX 2,140 per share, with a total value of £49,990.40. Insiders own 0.71% of the company’s stock.

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.